MX2012004087A - Sulfonamidas para la prevencion de diabetes. - Google Patents

Sulfonamidas para la prevencion de diabetes.

Info

Publication number
MX2012004087A
MX2012004087A MX2012004087A MX2012004087A MX2012004087A MX 2012004087 A MX2012004087 A MX 2012004087A MX 2012004087 A MX2012004087 A MX 2012004087A MX 2012004087 A MX2012004087 A MX 2012004087A MX 2012004087 A MX2012004087 A MX 2012004087A
Authority
MX
Mexico
Prior art keywords
diabetes
sulfonamides
prevention
medicaments
formula
Prior art date
Application number
MX2012004087A
Other languages
English (en)
Spanish (es)
Inventor
Lorenzo Piemonti
Luisa Daffonchio
Marcello Allegretti
Original Assignee
Dompe Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Spa filed Critical Dompe Spa
Publication of MX2012004087A publication Critical patent/MX2012004087A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51Y being a hydrogen or a carbon atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MX2012004087A 2009-10-06 2010-10-06 Sulfonamidas para la prevencion de diabetes. MX2012004087A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09172365A EP2308485A1 (en) 2009-10-06 2009-10-06 Sulfonamides for the prevention of diabetes
PCT/EP2010/064920 WO2011042465A1 (en) 2009-10-06 2010-10-06 Sulfonamides for the prevention of diabetes

Publications (1)

Publication Number Publication Date
MX2012004087A true MX2012004087A (es) 2012-08-23

Family

ID=41716341

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012004087A MX2012004087A (es) 2009-10-06 2010-10-06 Sulfonamidas para la prevencion de diabetes.

Country Status (24)

Country Link
US (2) US8846755B2 (enExample)
EP (2) EP2308485A1 (enExample)
JP (1) JP5745526B2 (enExample)
KR (1) KR101737656B1 (enExample)
CN (1) CN102639128B (enExample)
AU (1) AU2010305384B2 (enExample)
BR (1) BR112012007989B1 (enExample)
CA (1) CA2776021C (enExample)
CY (1) CY1117599T1 (enExample)
DK (1) DK2485724T3 (enExample)
EA (1) EA021788B1 (enExample)
ES (1) ES2570463T3 (enExample)
HR (1) HRP20160399T1 (enExample)
HU (1) HUE028132T2 (enExample)
IL (1) IL219038A (enExample)
ME (1) ME02385B (enExample)
MX (1) MX2012004087A (enExample)
NZ (1) NZ599171A (enExample)
PL (1) PL2485724T3 (enExample)
RS (1) RS54693B1 (enExample)
SI (1) SI2485724T1 (enExample)
SM (1) SMT201600126B (enExample)
WO (1) WO2011042465A1 (enExample)
ZA (1) ZA201202462B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
EP2308485A1 (en) 2009-10-06 2011-04-13 Dompé S.p.a. Sulfonamides for the prevention of diabetes
EP3281937A1 (en) * 2016-08-09 2018-02-14 Dompé farmaceutici S.p.A. Sulfonamides as gpr40- and gpr120-agonists
CN109890364B (zh) 2016-10-03 2023-10-17 儿童医疗中心公司 糖尿病肾病的预防和治疗

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1303249B1 (it) * 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
ITMI20010206A1 (it) 2001-02-02 2002-08-02 Dompe Spa Uso della metansolfonammide di (r)-ibuprofene e dei suoi sali non tossici per la preparazione di medicamenti per il trattamento e la prevenz
US20040242498A1 (en) * 2003-02-27 2004-12-02 Collins Tassie L. CXCR3 antagonists
PT1776336E (pt) 2004-03-23 2009-12-18 Dompe Spa Derivados de ácido 2-fenilpropiónico e composições farmacêuticas que os contêm
EP1579859B1 (en) 2004-03-25 2006-12-13 DOMPE' pha.r.ma s.p.a. Use of N-(2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury
WO2009117706A2 (en) * 2008-03-20 2009-09-24 Carolus Therapeutics, Inc. Methods of treatment using anti-mif antibodies
EP2308485A1 (en) 2009-10-06 2011-04-13 Dompé S.p.a. Sulfonamides for the prevention of diabetes
EP2308484A1 (en) * 2009-10-06 2011-04-13 Dompé S.p.a. Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets

Also Published As

Publication number Publication date
KR101737656B1 (ko) 2017-05-18
EP2485724B1 (en) 2016-02-10
SMT201600126B (it) 2016-07-01
US9556115B2 (en) 2017-01-31
US20130059908A1 (en) 2013-03-07
NZ599171A (en) 2014-03-28
HUE028132T2 (en) 2016-11-28
BR112012007989B1 (pt) 2019-10-22
US8846755B2 (en) 2014-09-30
EA021788B1 (ru) 2015-08-31
US20150011639A1 (en) 2015-01-08
AU2010305384A1 (en) 2012-04-26
DK2485724T3 (en) 2016-05-02
ZA201202462B (en) 2013-06-26
CA2776021A1 (en) 2011-04-14
ME02385B (me) 2016-09-20
WO2011042465A1 (en) 2011-04-14
CA2776021C (en) 2017-08-01
CN102639128A (zh) 2012-08-15
ES2570463T3 (es) 2016-05-18
EA201270512A1 (ru) 2012-11-30
RS54693B1 (sr) 2016-08-31
CY1117599T1 (el) 2017-04-26
EP2308485A1 (en) 2011-04-13
IL219038A0 (en) 2012-06-28
CN102639128B (zh) 2014-02-26
EP2485724A1 (en) 2012-08-15
PL2485724T3 (pl) 2016-07-29
HK1174557A1 (en) 2013-06-14
SI2485724T1 (sl) 2018-12-31
KR20120083889A (ko) 2012-07-26
JP5745526B2 (ja) 2015-07-08
JP2013506703A (ja) 2013-02-28
AU2010305384B2 (en) 2016-02-04
IL219038A (en) 2015-07-30
HRP20160399T1 (hr) 2016-05-20

Similar Documents

Publication Publication Date Title
UA106748C2 (uk) Похідні проліну як інгібітори катепсину
MX2010009736A (es) Compuesto heterociclico.
MX2011011854A (es) Dihidropirimidinonas para uso como inhibidores de la bace2.
MX2012007098A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
NZ597517A (en) 5-fluoropyrimidinone derivatives
MX2012007161A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
UA104885C2 (uk) Ізотіазолілоксифеніламідини та їх застосування як фунгіцидів
IN2012DN01233A (enExample)
MX2011011733A (es) Inhiibidores de dihidroorotato deshidrogenasa como compuestos virostaticos.
MX2010002419A (es) (ciclopropilfenil) feniloxamidas, metodo para su produccion y uso como un medicamento.
MX336381B (es) Boronatos como inhibidores de arginasa.
UA110471C2 (ru) 5-алкінілпіримідини
PH12013500942A1 (en) Triazolopyridine compounds
MX2010002461A (es) (carboxilalquilenfenil)feniloxamidas, metodo para su produccion y uso de las mismas como medicamento.
MX2011013884A (es) Sulfonamidas heterociclicas, usos y composiciones farmaceuticas de las mismas.
MX2011011178A (es) Compuesto de diaciletilendiamina.
MX2012008141A (es) Compuestos y metodos.
MX2011012739A (es) Derivados fluorados de aminotriazol.
WO2010147830A3 (en) Aminothiazole modulators of beta-3-adrenoreceptor
NZ597483A (en) N1-substituted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
NZ597570A (en) N1-acyl-5-fluoropyrimidinone derivatives
MX2014004920A (es) Nuevos derivados de pirazina.
JO2682B1 (en) Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof
TW200738627A (en) Trialkylsilyl-indoles
MX346090B (es) Derivados de pirrolidina usados como inhibidores de catepsina.

Legal Events

Date Code Title Description
FG Grant or registration